government
Evidence pageSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception – Guidance for Industry
U.S. Food and Drug Administration
accessed Sep 18, 2026Updated Sep 19, 2026
Original source
https://www.fda.gov/media/89920/download
fda.gov
Verification
| Verification | Not yet verified |
| Evidence level | — |
| Source | government |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (2)
FactAutologous Fat Grafting: US regulatory status (FDA) = Fat removed and reimplanted in the same person during the same surgical procedure may qualify for the 21 CFR 1271.15(b) exception if processing is limited to rinsing, cleansing, sizing and shaping (FDA final guidance, November 2017)FactAutologous Fat Grafting: Processed adipose cell products (US) = The FDA considers processing that isolates cellular components from fat, such as enzymatic digestion, to go beyond the same surgical procedure exception